High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$4.4M
$4,393,536
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| MAZE |
Maze Therapeutics, Inc.
|
President
10b5-1 Sell
|
2026-04-01 | $9,320 | S | Form 4 |
|
MAZE
S
Maze Therapeutics, Inc.
Bernstein Harold
• President
10b5-1 SellΔOwn -91.8%
2026-04-01
$100,636
|
||||||
| MAZE |
Maze Therapeutics, Inc.
|
President
10b5-1 SellΔOwn -91.8%
|
2026-04-01 | $100,636 | S | Form 4 |
|
MAZE
S
Maze Therapeutics, Inc.
Bernstein Harold
• President
10b5-1 SellΔOwn -75.7%
2026-04-01
$331,948
|
||||||
| MAZE |
Maze Therapeutics, Inc.
|
President
10b5-1 SellΔOwn -75.7%
|
2026-04-01 | $331,948 | S | Form 4 |
| MAZE |
Maze Therapeutics, Inc.
|
President
Other
|
2026-04-01 | $156,300 | M | Form 4 |
|
MAZE
S
Maze Therapeutics, Inc.
Bernstein Harold
• President
10b5-1 SellΔOwn -41.1%
2026-03-20
$296,977
|
||||||
| MAZE |
Maze Therapeutics, Inc.
|
President
10b5-1 SellΔOwn -41.1%
|
2026-03-20 | $296,977 | S | Form 4 |
| MAZE |
Maze Therapeutics, Inc.
|
President
Other
|
2026-03-20 | $156,300 | M | Form 4 |
| MAZE |
Maze Therapeutics, Inc.
|
President
10b5-1 Sell
|
2026-03-20 | $252,294 | S | Form 4 |
|
MAZE
S
Maze Therapeutics, Inc.
Bernstein Harold
• President
10b5-1 SellΔOwn -42.9%
2026-03-20
$187,169
|
||||||
| MAZE |
Maze Therapeutics, Inc.
|
President
10b5-1 SellΔOwn -42.9%
|
2026-03-20 | $187,169 | S | Form 4 |
|
MAZE
S
Maze Therapeutics, Inc.
Bernstein Harold
• President
10b5-1 SellΔOwn -98.8%
2026-03-10
$1,495,807Large
|
||||||
| MAZE |
Maze Therapeutics, Inc.
|
President
10b5-1 SellΔOwn -98.8%
|
2026-03-10 | $1,495,807Large | S | Form 4 |
| MAZE |
Maze Therapeutics, Inc.
|
President
Other
|
2026-03-10 | $312,600 | M | Form 4 |
| MAZE |
Maze Therapeutics, Inc.
|
President
10b5-1 Sell
|
2026-03-10 | $17,753 | S | Form 4 |
| MAZE |
Maze Therapeutics, Inc.
|
President
Other
|
2026-02-02 | $156,300 | M | Form 4 |
| MAZE |
Maze Therapeutics, Inc.
|
President
10b5-1 Sell
|
2026-02-02 | $4,723 | S | Form 4 |
|
MAZE
S
Maze Therapeutics, Inc.
Bernstein Harold
• President
10b5-1 SellΔOwn -98.3%
2026-02-02
$275,271
|
||||||
| MAZE |
Maze Therapeutics, Inc.
|
President
10b5-1 SellΔOwn -98.3%
|
2026-02-02 | $275,271 | S | Form 4 |
|
MAZE
S
Maze Therapeutics, Inc.
Bernstein Harold
• President
10b5-1 SellΔOwn -58.1%
2026-02-02
$383,816
|
||||||
| MAZE |
Maze Therapeutics, Inc.
|
President
10b5-1 SellΔOwn -58.1%
|
2026-02-02 | $383,816 | S | Form 4 |
| MAZE |
Maze Therapeutics, Inc.
|
President
10b5-1 Sell
|
2026-02-02 | $26,523 | S | Form 4 |
| MAZE |
Maze Therapeutics, Inc.
|
President
10b5-1 Sell
|
2026-01-07 | $1,011,299Large | S | Form 4 |
| MAZE |
Maze Therapeutics, Inc.
|
President
Equity Compensation
|
2026-01-07 | $0 | M | Form 4 |
| MAZE |
Maze Therapeutics, Inc.
|
President
Other
|
2026-01-07 | $262,126 | M | Form 4 |